Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Efficacy of Transversus Abdominis Plane (TAP) Block Techniques: Surgeon vs Anesthesia - Ultrasound Guidance

Not Applicable

Completed

Conditions: Non-inferiority Trial
Post Operative Analgesia

Interventions: Procedure: TAP block administered by Surgery
Procedure: TAP block administered by Anesthesia

First Posted Date: 2018-07-05

Last Posted Date: 2018-09-17

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 60

Registration Number: NCT03577912

Locations: 🇺🇸
Beth Israel Medical Center, Boston, Massachusetts, United States

Thiamine as a Renal Protective Agent in Septic Shock

Phase 2

Completed

Conditions: Thiamine Deficiency
Sepsis
Kidney Injury

Interventions: Drug: Placebo
Drug: Thiamine Hydrochloride

First Posted Date: 2018-06-08

Last Posted Date: 2023-06-27

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 95

Registration Number: NCT03550794

Locations: 🇺🇸
Northshore University Hospital, Manhasset, New York, United States
🇺🇸
Long Island Jewish Hospital, Queens, New York, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 1 locations

Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)

Phase 2

Completed

Conditions: Ovarian Cancer

Interventions: Other: Thromboprophylaxis
Drug: Enoxaparin
Drug: Enoxaparin + Rosuvastatin

First Posted Date: 2018-05-22

Last Posted Date: 2025-01-23

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 24

Registration Number: NCT03532139

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Device: RSI
Device: MRI

First Posted Date: 2018-04-11

Last Posted Date: 2024-07-23

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 10

Registration Number: NCT03495115

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Pecto-Intercostal Fascial Block for Postoperative Analgesia After Cardiac Surgery

Phase 3

Completed

Conditions: Coronary Artery Disease
Sternal Pain

Interventions: Drug: Bupivacaine Group
Other: Placebo

First Posted Date: 2018-03-29

Last Posted Date: 2020-08-03

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 80

Registration Number: NCT03482973

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Discussing Stopping Cancer Screening and Prognosis With Older Adults

Not Applicable

Completed

Conditions: Cancer Screening

Interventions: Other: Prognosis information and Provider Scripts

First Posted Date: 2018-03-29

Last Posted Date: 2024-01-30

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 90

Registration Number: NCT03480282

Locations: 🇺🇸
BIDMC Affiliated Physicians Group, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Device: CESM
Device: MRI

First Posted Date: 2018-03-29

Last Posted Date: 2025-01-09

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 132

Registration Number: NCT03482557

Locations: 🇺🇸
Beth Israel Deaconess, Boston, Massachusetts, United States

Managing Side Effects in Clinical Practice

Not Applicable

Completed

Conditions: Functional Gastrointestinal Disorders

Interventions: Other: Standard of Care

First Posted Date: 2018-03-23

Last Posted Date: 2022-12-15

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 31

Registration Number: NCT03475550

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

EEG Changes With Guided Online Meditation

Not Applicable

Completed

Conditions: Meditation

Interventions: Behavioral: Meditation
Device: Enobio 32- EEG machine

First Posted Date: 2018-03-09

Last Posted Date: 2024-03-28

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 13

Registration Number: NCT03459690

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

OKS for the Treatment of Hemispatial Neglect

Not Applicable

Withdrawn

Conditions: Neglect, Sensory
Neglect, Hemispatial
Neglect, Hemisensory

Interventions: Device: OKS

First Posted Date: 2018-03-02

Last Posted Date: 2024-06-05

Lead Sponsor: Beth Israel Deaconess Medical Center

Registration Number: NCT03451708

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy